November/December 2011 Issue
When the whole so closely resembles the individual parts, where is the big picture, or the path to continuous improvement?
Effective change must improve business performance, and not just a process.
Pharmaceutical manufacturers consistently spend too much on downstream logistics services. Clean sheet modeling helps them plan networks around real costs, rather than historical precedents.
As legislators and the courts re-examine an old fashioned word, sins of omission will count as much, if not more, than sins of commission.
For manufacturers who lack formulation and process knowledge, the benefits of getting to market fast can be outstripped by the costs of unexpected failures.
A look at data on how the industry chooses with whom to outsource, and what it really thinks about potential partners.
Its time to make counterfeiting less economically tantalizing.
Big Pharmas concentration on digital marketing nearly tripled in 2011 with consumers increasing reliance on technical gadgets and social media.